.png){kind=logo}
UiO:RealArt
The UiO:RealArt convergence environment aims to combat the methodological stagnation in perinatal epidemiology, by uniting machine learning, pharmacological and biological sciences, and social and education sciences.
International Alliance for PharmacoGenetic Epidemiology Excellence (iAPOGEE)
The purpose of the iAPOGEE consortium is to enhance collaboration within education and research in pharmaco- and genetic epidemiology between the partner universities and institutions.
ERC Start Grant "DrugsInPregnancy"
Medication prescribed during pregnancy may play an unrecognized role in the development of neurodevelopmental disorders. In this project we have the unique opportunity to use several population-based registries and a population-based birth cohort including over 100,000 mother-child pairs and biological data (DNA samples) to study how medications may act on the offspring. This possibility offers novel pharmaceutical insight into the safety of medications.
HEALTHx2
The aim of the project is to provide the evidence base for important clinical decisions: whether to treat a perinatal psychiatric disorder or no. It will also facilitate women empowerment in developing an evidence-based understanding of the benefits and risks of perinatal use of antidepressants.
DRUG-TRIAD
The aim of the project is to establish the contribution of drug exposure in mother-father-child triads on later cardio-metabolic dysfunctions in children and youth.
ConcePTION
The aim of the project is to develop information to guide decision making for the safe and effective use of medications during pregnancy and breastfeeding.
COVID-19 projects
We are involved in several international research project focusing on treatment of COVID-19, and medication use.
Vac4EU
This study's purpose is to conduct active surveillance post-conditional approval for people receiving COVID-19 vaccines from Pfizer-BioNTech and Moderna. This project focuses on mapping whether there is an increased risk of side effects across the European population and in special population groups, such as pregnant women.
EU-COVID-19
A multinational registry- based linkage study with focus on risk and protective factors, clinical outcomes and mental health". The aim of this international interdisciplinary project is to provide knowledge about the populations’ risk factors and health consequences of COVID-19.
Nordic COHERENCE
The project will establish an internationally unique multi-country database network with data from healthcare registers in Denmark, Norway, Sweden and Scotland. The database will cover health information for 25 million individuals, with the purpose of conducting epidemiological studies on Covid-19.
VERDI
The project prioritizes women and children in the research on new coronavirus variants. The Department of Pharmacy, University of Oslo, is contributing to the project with data from the Norwegian Health Registries.
MinSafeStart
The aim of the project is to investigate whether a patient centered app can reduce symptoms of nausea and vomiting in pregnancy, and provide a better quality of life.
Finalized Projects:
CONSIGN – Covid-19 infectiOn aNd medicineS In pregnancy
The aim of this project is to provide adequate data on the impact of COVID-19 in pregnancy to guide decision-making about vaccine indications, vaccination policies, and treatment options for COVID-19 disease and associated complications.
ACCESS
The goal is to establish a European infrastructure prepared for the monitoring of the COVID-19 vaccines and for conducting specific studies, and to provide documented information about the feasibility to address different outcomes: coverage, safety and effectiveness.
COVID-19 survey pregnant and lactating women
In collaboration with researchers from several European countries, the aim is to investigate the impact of the COVID-19 pandemic on pregnant and lactating women.